Evidence map›Paper›PMID 32473637›Full record

ArticleWorld journal of surgical oncology2020

MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.

Ke Fu, Ling Zhang, Rui Liu, Qi Shi, Xue Li, Min Wang

Open access · goldAbstract read
In one paragraph

Article in World journal of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Mechanistic Insights into the Anticancer Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ke FuDepartment of Gynecology and Obstetrics, The Fourth People's Hospital of Liaocheng, City, Shandong Province, Liaocheng, China.
Ling ZhangDepartment of Gynecology and Obstetrics, Liaocheng People's Hospital, Liaocheng City, Shandong Province, China.
Rui LiuDepartment of Postgraduate, Shandong First Medical University, Jinan City, Shandong Province, China.
Qi ShiDepartment of Postgraduate, Shandong First Medical University, Jinan City, Shandong Province, China.
Xue LiDepartment of Postgraduate, Shandong First Medical University, Jinan City, Shandong Province, China.
Min WangDepartment of Reproductive Genetics, Liaocheng People's Hospital, No. 67, Dongchang West Road, Liaocheng City, 252000, Shandong Province, China. fuyipo2059616350@163.com.
Shandong First Medical University · CNLiaocheng People's Hospital · CNThe Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMiR-125 has been shown to be involved in a variety of cancers, including cervical cancer (CC). Here, our goal was to explore miR-125 functional role and molecular mechanism in cervical cancer development and progression.

methodsqRT-PCR was employ to detect miR-125 and VEGF mRNA expression. Western blot was applied for testing protein levels (VEGF, E-cadherin, N-cadherin, vimentin, AKT, p-AKT, PI3K, and p-PI3K). MTT and transwell assays were used for detecting cervical cancer cell progression, including cell viability, migration, and invasion.

resultsWe observed that miR-125 was downregulated, whereas VEGF was upregulated in cervical cancer tissues and cell lines (CaSki and SiHa). MiR-125 inhibited the proliferation, invasion, and migration by targeting VEGF in cervical cancer. Moreover, miR-125 negatively regulated VEGF expression in cervical cancer tissues. Finally, we demonstrated that miR-520d-5p inhibited the activation of PI3K/AKT signaling pathway.

conclusionIn conclusion, the findings demonstrated that miR-125 inhibited cervical cancer progression and development by suppression VEGF and PI3K/AKT signaling pathway.

Indexed as

Gene Expression Regulation, NeoplasticAdultAnimalsCell Line, TumorCell MovementCell ProliferationCervix UteriDisease ProgressionDown-RegulationEpithelial-Mesenchymal TransitionFemaleGene Knockdown TechniquesHumansMiceMicroRNAsMiddle AgedAKT1 protein, humanMicroRNAsMIRN125 microRNA, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktVascular Endothelial Growth Factor AVEGFA protein, humanCervical cancermiR-125PI3K/AKTVEGF

Identifiers

PMID32473637
PMCPMC7261381
OpenAlexW3029286837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.